15 search results for: disease severity

Missing material
Content temporarily unavailable
Identifying BP: How do symptoms of BP and their severity alter patient diagnosis?

Dr. Victoria Werth explains how diagnosing BP can pose many difficulties in patients due to the variation of symptoms and symptom severity. Dr. Werth also discusses what burden and challenges BP patients might expect as a result.

Missing material
Content temporarily unavailable
ERS-ISIAN 2025 | Type 2 Inflammation: Links with Severe/Uncontrolled CRSwNP

Prof. Vibeke Backer provides an insightful presentation on the association of type 2 inflammation and the pathogenesis and management of severe and uncontrolled CRSwNP.

Missing material
Content temporarily unavailable
Compounded Burden of Co-existing Type 2 Airway Diseases

In this video soundbite from the EAACI 2025 symposium, Dr. Brian Lipworth discusses that co-existing type 2 inflammatory diseases are common in patients with CRSwNP​ & increasing severity of asthma is associated with higher severity of CRS and prevalence of nasal polyps. Additionally, he explains that patient burden is substantially greater when asthma and CRSwNP are co-existing.

Missing material
Content temporarily unavailable
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

The ERS-ISIAN 2025 symposium, featuring Prof. Vibeke Backer and Prof. Sietze Reitsma, titled "Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions," will delve into the complexities of the role of type 2 inflammation in CRSwNP.

Missing material
Content temporarily unavailable
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.

Missing material
Content temporarily unavailable
Understanding IL-33: A Key Factor in COPD Pathogenesis

Explore the role of interleukin (IL)-33 in chronic obstructive pulmonary disease (COPD) pathophysiology and its potential as a therapeutic target.

Missing material
Content temporarily unavailable
CRSwNP Triathlon: An Interactive Learning Experience

Embark on this interactive triathlon challenge to uncover the interplay of type 2 inflammation, barrier dysfunction, and neuroimmune dysregulation in the disease pathology of CRSwNP.

Missing material
Content temporarily unavailable
ADVENT On Air | Expert Discussions in Dermatology

Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

Missing material
Content temporarily unavailable
The Burden in Patients with CRSwNP and Coexisting Asthma

This video supports improved clinical awareness and encourages comprehensive care strategies for patients living with both CRSwNP and asthma.

Missing material
Content temporarily unavailable
Partnering With Patients: Scores That Matter in CRSwNP

Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life

Missing material
Content temporarily unavailable
Going Beyond the Scope in Eosinophilic Esophagitis

This infographic explores distensibility in EoE, including assessment with EndoFLIP.

Missing material
Content temporarily unavailable
EoE Pocket Guide

The digital EoE Pocket Guide is an at-your-fingertips resource on symptoms and adaptive behaviors, EREFS scoring, and histologic features in EoE.